# Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia

> **NCT07384702** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 230 (estimated)

## Conditions studied

- Bacteremia Due to Staphylococcus Aureus

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** No antiplatelet treatment

## Key facts

- **NCT ID:** NCT07384702
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2030-06
- **Final completion:** 2030-06
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07384702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07384702, "Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07384702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*